» Authors » Praful Balavant Deshpande

Praful Balavant Deshpande

Explore the profile of Praful Balavant Deshpande including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 45
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Padya B, Fernandes G, Hegde S, Kulkarni S, Pandey A, Deshpande P, et al.
Pharmaceutics . 2023 Nov; 15(11). PMID: 38004573
The therapeutic effectiveness of the most widely used anticancer drug 5-fluorouracil (5-FU) is constrained by its high metabolism, short half-life, and rapid drug resistance after chemotherapy. Although various nanodrug delivery...
2.
Shavi G, Nayak U, Reddy M, Ginjupalli K, Deshpande P, Averineni R, et al.
Mater Sci Eng C Mater Biol Appl . 2017 Apr; 75:535-544. PMID: 28415496
The purpose of the present study was to fabricate PLGA 50:50 and PLA microspheres for controlled delivery of anastrozole. The microspheres were prepared by oil-in-water (o/w) emulsion/solvent evaporation technique and...
3.
Deshpande P, Gurram A, Deshpande A, Shavi G, Musmade P, Arumugam K, et al.
Life Sci . 2016 Aug; 162:125-37. PMID: 27544752
Aim: The aim of the present study was to develop nanoproliposomes of lercanidipine, in order to overcome its poor biopharmaceutical properties and to improve its therapeutic efficacy in treating hypertension....
4.
Shavi G, Nayak U, Maliyakkal N, Deshpande P, Raghavendra R, Kumar A, et al.
Life Sci . 2015 Oct; 141:143-55. PMID: 26423561
Aim: Formulation and evaluation of anastrozole, an anti-cancer drug loaded in different biodegradable polymeric nanoparticles. Materials And Methods: Different carrier systems such as poly(lactide-co-glycolide) (PLGA 50:50), poly(lactic-acid) (PLA) and poly(ε-caprolactone)...
5.
Shavi G, Reddy M, Raghavendra R, Nayak U, Kumar A, Deshpande P, et al.
J Liposome Res . 2015 Apr; 26(1):28-46. PMID: 25853340
The aim of present study was to develop conventional and PEGylated (long circulating), liposomes containing anastrozole (ANS) for effective treatment of breast cancer. ANS is a third-generation non-steroidal aromatase inhibitor...
6.
Reddy G, Nayak U, Deshpande P, Mutalik S
ScientificWorldJournal . 2014 Dec; 2014:421931. PMID: 25525619
The present study was aimed at the development of gastroretentive floating pulsatile release tablets (FPRTs) of lercanidipine HCl to enhance the bioavailability and treat early morning surge in blood pressure....
7.
Deshpande P, Kumar G, Kumar A, Shavi G, Karthik A, Reddy M, et al.
PDA J Pharm Sci Technol . 2012 Feb; 65(3):333-44. PMID: 22293238
Lay Abstract: Supercritical fluid technology has recently drawn attention in the field of pharmaceuticals. It is a distinct conception that utilizes the solvent properties of supercritical fluids above their critical...
8.
Deshpande P, Dandagi P, Udupa N, Gopal S, Jain S, Vasanth S
Pharm Dev Technol . 2009 Sep; 15(4):369-78. PMID: 19772377
The aim of the present study was to formulate and evaluate controlled release polymeric ocular delivery of acyclovir. Reservoir-type ocular inserts were fabricated by sandwiching hydroxypropyl methylcellulose (HPMC) matrix film...